Therafectin is primarily used in medical and therapeutic applications, particularly in the treatment of inflammatory and autoimmune conditions. It is often prescribed to manage symptoms of rheumatoid arthritis, helping to reduce joint pain, swelling, and stiffness by modulating the immune response. Additionally, it has shown efficacy in treating other chronic inflammatory disorders, such as lupus and psoriasis, by suppressing overactive immune reactions that contribute to tissue damage. Therafectin is also being explored for its potential in managing certain types of chronic pain and in post-surgical recovery to minimize inflammation and promote healing. Its ability to target specific pathways in the immune system makes it a valuable option for patients who do not respond well to conventional therapies.